Skip to main content
Clinical Trials/NCT05000879
NCT05000879
Completed
Not Applicable

A Randomized Controlled Trial of Mental Health Outcomes and Putative Targets of an Online Mindfulness Program for New and Expectant Mothers

University of Colorado, Boulder1 site in 1 country60 target enrollmentNovember 16, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Depression
Sponsor
University of Colorado, Boulder
Enrollment
60
Locations
1
Primary Endpoint
Rate of change in anxiety symptoms
Status
Completed
Last Updated
last year

Overview

Brief Summary

The purpose of this investigation is to conduct a randomized trial comparing a web-based Mindful Mood Balance for Moms course without coaching support to waitlist control among pregnant or early parenting women with depression histories.

Detailed Description

Mindfulness-based cognitive therapy (MBCT) prevents depressive relapse and reduces residual depression symptoms among adults with recurrent depression not currently in episode. Women in perinatal or early parenting years constitute a significant portion of this at-risk population with a history of depression for whom MBCT was designed. Novel delivery formats that provide access to core knowledge and skills of MBCT could increase public health impact-particularly for perinatal or early parenting women-but it is unclear whether such formats have comparable mental health outcomes and changes in putative targets as in-person MBCT. In the present study, we planned to randomize 60 pregnant or early parenting women with a history of major depression and current residual depressive symptoms to MMB for Moms, a web-based course that teaches skills from MBCT customized specifically for pregnant and postpartum women, or waitlist control. We planned to address the following specific aims: Aim 1. We evaluated the extent to MMB for Moms was associated with significant reduction in residual depression symptoms as compared to WLC. We predicted the rate of change in depression symptoms across the study would be greater on average for participants randomized to MMB for Moms relative to those randomized to WLC. Aim 2. We evaluated the extent to MMB for Moms significantly engaged the putative target of decentering as compared to WLC. We predicted the rate of change in decentering across the study would be greater on average for participants randomized to MMB for Moms relative to participants randomized to WLC. Aim 3. We evaluated the extent to MMB for Moms significantly engaged the putative target of self-compassion as compared to WLC. We predicted the rate of change in self-compassion across the study would be greater on average for participants randomized to MMB for Moms relative to participants randomized to WLC.

Registry
clinicaltrials.gov
Start Date
November 16, 2018
End Date
August 20, 2019
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

CHRISTINA METCALF

Senior Instructor

University of Colorado, Boulder

Eligibility Criteria

Inclusion Criteria

  • pregnant or having had a child within the past 36 months, \*
  • 18 years of age or older,
  • having a history of one or more prior major depressive episode (as assessed by a single question, "Have you had a history of mood concerns or major depression?")
  • a current PHQ-9 score of \<= 14, and
  • endorses ability to read and write fluently in English.

Exclusion Criteria

  • meeting criteria for current moderately severe depression symptoms (as assessed by the PHQ-9 \>= 15),
  • current imminent suicidality (as assessed by the PHQ-9), and
  • indication of other disorders or symptoms that necessitate priority treatment.

Outcomes

Primary Outcomes

Rate of change in anxiety symptoms

Time Frame: Through 6-month follow-up

Change in the severity of anxiety symptoms will be evaluated by the 3. Generalized Anxiety Disorder-7 (GAD-7)

Rate of change in depression symptoms

Time Frame: Through 6-month follow-up

Change in the severity of depressive symptoms will be evaluated by the Patient Health Questionnaire-9 (PHQ-9)

Rate of change in self-compassion

Time Frame: Through 6-month follow-up

Change in self-compassion will be evaluated by the Self-Compassion Scale (SCS)

Depressive Relapse Status

Time Frame: Through 6-month follow-up

Rate of depressive relapse will be assessed using the Lifetime Depression Assessment Self-report (LIDAS), adapted to reference the past 3 or 6 months based on survey completion.

Rate of change in decentering

Time Frame: Through 6-month follow-up

Change in decentering will be evaluated by the Experiences Questionnaire-Decentering subscale

Study Sites (1)

Loading locations...

Similar Trials